Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Nexalin Technology, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q1 2026
- Shares held
- 848.5K
- −217.4K (−20.4%) vs. Q1 2026
- Total value
- $281.6K
- −$91.9K (−24.6%) vs. Q1 2026
- New holders
- 4
- 2 more added
- Sold out
- 7
- 5 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $281.6K |
| Q1 2026 | 23 | $373.6K |
| Q4 2025 | 19 | $948.5K |
| Q3 2025 | 20 | $638.3K |
| Q2 2025 | 21 | $1.31M |
| Q1 2025 | 17 | $774.5K |
| Q4 2024 | 19 | $1.04M |
| Q3 2024 | 15 | $286.8K |
| Q2 2024 | 13 | $466.9K |
| Q1 2024 | 5 | $88.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 5 | $36.0K |
| Q2 2023 | 4 | $11.0K |
| Q1 2023 | 7 | $45.5K |
| Q4 2022 | 7 | $32.5K |
| Q3 2022 | 2 | $21.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Nexalin Technology, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PEAK6 LLC | 240,210 | $79.3K | 0.00% | −144,250−37.5% | Reduced |
| Geode Capital Management, LLC | 139,583 | $46.1K | 0.00% | −107,454−43.5% | Reduced |
| Vanguard Capital Management LLC | 126,536 | $41.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 75,398 | $24.9K | 0.00% | +75,398 | New |
| Jane Street Group, LLC | 65,497 | $21.6K | 0.00% | +54,987+523.2% | Added |
| Vanguard Fiduciary Trust Co | 51,386 | $17.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 32,300 | $10.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26,825 | $8.85K | 0.00% | +4,636+20.9% | Added |
| Kovack Advisors, Inc. | 22,325 | $8.04K | 0.00% | −1,000−4.3% | Reduced |
| Northern Trust Corp | 24,100 | $7.95K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 13,497 | $5.41K | 0.00% | −9,426−41.1% | Reduced |
| Raymond James Financial Inc | 12,100 | $3.99K | 0.00% | 00.0% | Unchanged |
| Integrated Investment Consultants, LLC | 10,000 | $3.30K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,111 | $697 | 0.00% | −10.0% | Reduced |
| Advisor Group Holdings, Inc. | 2,100 | $693 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,459 | $481 | 0.00% | +1,459 | New |
| Farther Finance Advisors, LLC | 1,000 | $330 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,000 | $330 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 873 | $288 | 0.00% | +873 | New |
| Barclays PLC | 241 | $80 | 0.00% | +241 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −23,453−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,928−100.0% | Sold out |
| Elevation Advisory Partners LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,901−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,676−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,447−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |